An Inhalable Medicament Comprising Tiotropium

Patent No. EP3143998 (titled "An Inhalable Medicament Comprising Tiotropium") was filed by Teva Pharmaceuticals on Dec 6, 2012. The application was issued on May 22, 2019.

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
M INNOVATIVE PROPERTIESFeb 21, 2020VOSSIUS & PARTNER PATENTANWALTE RECHTSANWALTE MBB

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP3143998

TEVA PHARMACEUTICALS
Application Number
EP16185402A
Filing Date
Dec 6, 2012
Status
Revoked
Jun 11, 2024
Publication Date
May 22, 2019